A New Weapon to Fight Neuroblastoma (VIDEO) Michigan Medicine - University of Michigan This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption After the first year of receiving the novel treatment combination in the COG trial, 9 out of 17 children with relapsed or resistant neuroblastoma saw either a complete or partial remission -- a 53 percent response rate compared to the typical 10 to 12 percent response rate from chemotherapy or biologic therapy alone. Credit University of Michigan Health System Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.